ScriptsMD Makes Semaglutide Weight Loss Treatment Accessible and Affordable

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

DELRAY BEACH, Fla., Nov. 4, 2024 /PRNewswire/ — ScriptsMD is an innovative healthcare solution that provides Americans with affordable access to semaglutide weight loss treatment while addressing nationwide medication shortages. The company’s comprehensive program delivers semaglutide at just $239 monthly*, making effective weight management accessible to more Americans in a landscape where similar treatments often cost three to four times more.

*Prices subject to change.

Recent clinical studies conducted by The New England Journal of Medicine demonstrate semaglutide’s remarkable effectiveness, with participants losing an average of 14.9% body weight over a 68-week trial period. Through ScriptsMD’s streamlined telehealth platform, patients can access this proven treatment at just $7.97 daily, including medication, consultation, and support.

ScriptsMD’s all-inclusive program provides:

  • Semaglutide medication
  • Free consultation with U.S. board-certified physicians and prescription
  • Complete injection kit and supplies
  • Anti-nausea medication
  • Temperature-controlled overnight shipping
  • 24/7 provider support
  • Ongoing medical supervision and dosage adjustments

The company’s efficient process begins with a 5-minute online health questionnaire to ensure comprehensive patient evaluation. Qualified patients receive prescriptions in 1-3 days, with medication delivered in 1-2 days through temperature-controlled shipping. This acute, personalized attention helps patients start their weight loss journey without delay.

According to The University of Pennsylvania, as many as 5 million Americans were prescribed Semaglutide in 2023. ScriptsMD distinguishes itself through transparent pricing with no insurance requirements or hidden fees. The program maintains consistent monthly pricing regardless of dosage, up to 1.5mg weekly, backed by a 100% satisfaction guarantee. Treatment is managed through a secure, LegitScript-certified platform with McAfee protection, ensuring patient privacy and data security.

For more information about ScriptsMD’s Semaglutide program and telehealth services, visit ScriptsMD.

ScriptsMD is revolutionizing healthcare access through its telehealth platform. By connecting patients with board-certified physicians and providing affordable medication access, ScriptsMD makes quality healthcare more accessible to Americans. The company’s commitment to patient care includes 24/7 support, transparent pricing, and comprehensive treatment programs.

Media Contact
Info@usscriptsMD.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/scriptsmd-makes-semaglutide-weight-loss-treatment-accessible-and-affordable-302296000.html

SOURCE Scripts MD

Staff

Recent Posts

University of Arizona Study Finds Openwater’s Open-LIFU 2.0 Device Achieves Significant Depression Symptom Reduction After Less Than Two Hours Total Treatment Time

Clinical Trial Utilizing Low-Intensity Transcranial Focused Ultrasound Pulses to Key Brain Region Shows Notable Reduction…

2 hours ago

Alcon Publishes Agenda for 2025 Annual General Meeting

Alcon welcomes its shareholders to its third in-person AGM Alcon Board of Directors proposes to…

5 hours ago

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #earnings--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release…

5 hours ago

BIZCLIK MEDIA PUBLISHES APRIL EDITION OF HEALTHCARE DIGITAL

The April edition of Healthcare Digital features exclusive insights from leaders at Abzena, Arcutis Biotherapeutics, Spotfire, S&P…

6 hours ago

TALON selects Litchfield Underwriters to provide Comprehensive Stop-Loss Coverage for Transformative Equitable Healthcare Pricing Network

PORTSMOUTH, N.H., April 4, 2025 /PRNewswire/ -- Litchfield Underwriters, industry leaders in providing superior self-funded…

6 hours ago

Google Cloud and Ai2 Commit $20M to Advance AI-Powered Research for the Cancer AI Alliance

Google Cloud to provide advanced and secure technology, while Ai2 to lead AI training and…

6 hours ago